Alendronate vs Denosumab: Comparing Long-Term Efficacy, Safety, and Costs for Osteoporosis
Jun 2 2025
Lung Cancer Screening for Smokers: Who Qualifies and New Targeted Therapies
Discover who qualifies for lung cancer screening under new 2023 guidelines. Learn about low-dose CT scans, targeted therapy advances like osimertinib, and how early detection boosts survival rates from 6% to 59%.
